Sabby Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-43,000
Closed -$474K 103
2019
Q1
$474K Buy
+43,000
New +$1.36M 0.23% 31
2016
Q3
Sell
-7,136
Closed -$921K 326
2016
Q2
$1.04M Buy
+7,136
New +$818K 0.05% 156
2015
Q4
Sell
-26,352
Closed -$4.06M 349
2015
Q3
$3.73M Buy
+26,352
New +$5.91M 0.15% 104
2014
Q3
Sell
-20,919
Closed -$1.93M 278
2014
Q2
$1.93M Buy
20,919
+8,344
+66% +$733K 0.08% 108
2014
Q1
$1.14M Buy
12,575
+11,075
+738% +$1.24M 0.06% 131
2013
Q4
$154K Sell
1,500
-42,250
-97% -$2.98M 0.01% 190
2013
Q3
$2.77M Buy
+43,750
New +$2.46M 0.18% 68

Other funds holding NVAX

Sabby Management's NVAX Position: Q2 2019 in Review

Sabby Management sold out of Novavax (NVAX) in Q2 2019, closing a stake of 43,000 shares — an estimated $474K sold.

Sabby Management first reported a position in NVAX in Q3 2013 and held it in 7 quarters. The position peaked at $3.73M in Q3 2015. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • Sabby Management reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • Sabby Management sold 43,000 Novavax shares in Q2 2019, an estimated $474K.
  • Sabby Management first reported a position in Novavax in Q3 2013 and held it in 7 quarters.
  • Sabby Management's Novavax position peaked at $3.73M in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on Sabby Management's 13F filing for Q2 2019, filed 14 Aug 2019.